Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases
Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection
Why omicron is more infectious than other coronavirus variants | Science News
Omicron seen as milder coronavirus but scientists aren't sure - Los Angeles Times
Georgia State Study Finds COVID-19 Omicron Variant Leads to Less Severe Disease in Mice - Georgia State University News - College of Arts and Sciences, Coronavirus Research, Press Releases, Research, University Research -
Understanding Omicron, the new COVID-19 variant of concern | COVID | UT Southwestern Medical Center
Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study - The Lancet Infectious Diseases
TaqPath COVID-19 Tests Support Detection of SARS-CoV-2 in Samples Containing the Omicron Variant - Clinical Conversations
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study - The Lancet Microbe
Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against Omicron
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases
Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry - The Lancet Oncology
Omicron subvariant XBB jumps to 18% of U.S. COVID cases, CDC says | Reuters
Harvard advisers on Omicron, shifting protocols – Harvard Gazette
SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response
Omicron Subvariant XBB.1.5: What to Know
Pay attention to Omicron, worry more about Delta' | MUSC | Charleston, SC
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR
IJMS | Free Full-Text | Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
Understanding BA.2's rise across the U.S. and Oregon : Oregon Health News Blog
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada - The Lancet Healthy Longevity
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet
Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins | National Institutes of Health (NIH)